Purchase Order 75F40119P10272
Award Date 6/18/19
Potential Completion Date 11/25/24
Potential Value $402K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded Illumina, Inc. a firm fixed price purchase order for a MiSeq Silver Support Plan Maintenance Service Contract. The potential value of the contract is $256,914.50. The contract was not set aside, and the period of performance ran from February 14, 2019 to December 5, 2020. Illumina, Inc. is a for-profit manufacturer that provides a range of genomic sequencing instruments, reagents, and services to federal agencies...
- This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
- This is a $84,332.60 firm fixed price purchase order contract awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc. for a MiSeq Silver Support Plan. The contract has an ultimate completion date of August 14, 2026 and was awarded on August 15, 2020. This award does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions, has previously received federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- The U.S. government agency awarded a $12,888.96 firm fixed-price purchase order contract to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The "MISEQ SILVER SUPPORT PLAN" contract, which does not have a set-aside designation, is for the provision of maintenance and support services for the agency's MiSeq sequencing platform. Illumina, Inc., the prime contractor, is a for-profit manufacturer of goods headquartered in San...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $75,448 contract provides a MiSeq support plan to maximize the performance and ensure continued operation of the MiSeq sequencing system. The sequencing data generated by the MiSeq will be used to evaluate the genetic consistency and safety of viral vaccines, as well as genetic characterization of...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
- This $81,810 firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq instrument and does not have a set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention...
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide a diagnostic check and system upgrades for the MiSeq Whole Genome Sequencer at six FDA laboratories. The $84,733.20 contract has a completion date of December 31, 2022 and was sole-sourced to Illumina due to the proprietary nature of the MiSeq technology. Illumina has previously provided sequencing systems,...
- This is a firm fixed price delivery order awarded by the Northeast Area of the federal agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $15,078.24 contract is for a MiSeq silver support plan, which provides maintenance and technical support services for Illumina's MiSeq sequencing system. The award does not have a set-aside designation. Illumina has a history of providing a range of sequencing platforms, consumables, and bioinformatics products to...